<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153955</url>
  </required_header>
  <id_info>
    <org_study_id>H00018239</org_study_id>
    <nct_id>NCT04153955</nct_id>
  </id_info>
  <brief_title>Earlier Mobilization Post Acute Thrombectomy</brief_title>
  <acronym>EMPATHY-II</acronym>
  <official_title>Earlier Mobilization Post Acute Thrombectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brian Silver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase III trial trying to determine whether 12-hour bed rest following thrombectomy
      for ischemic stroke is non-inferior to 24-hour bed rest by measure of outcomes on the
      modified Rankin Scale (mRS) at 90 days post bed rest.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Assessors blind to the subject's treatment/arm will do the evaluations at 90 days</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>90 Day Modified Rankin Scale (mRS) score</measure>
    <time_frame>90 days post bed rest</time_frame>
    <description>Proportion of patients with a modified Rankin Scale score (min 0, max 5 with 0 being the best outcome) of 0-2 at 90 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>Duration of hospitalization stay, average 5 days</time_frame>
    <description>Determine whether rates of pneumonia are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous Thromboembolism</measure>
    <time_frame>Duration of hospitalization stay, average 5 days</time_frame>
    <description>Determine whether rates of Venous Thromboembolism (VTE) are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Worsening</measure>
    <time_frame>Duration of hospitalization stay, average 5 days</time_frame>
    <description>Determine whether rates of neurological worsening are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>90 days post bed rest</time_frame>
    <description>Determine whether rates of readmission are at least similar in the two arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Duration of hospitalization stay, average 5 days</time_frame>
    <description>Determine whether length of hospital stay are at least similar in the two arms. This will be measured in days.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">852</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke, Acute</condition>
  <condition>Stroke, Ischemic</condition>
  <arm_group>
    <arm_group_label>12-Hour Bed Rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be mobilized 12 hours after undergoing thrombectomy per usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24-Hour Bed Rest</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be mobilized 24 hours after undergoing thrombectomy per usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobilization</intervention_name>
    <description>Any movement out of bed</description>
    <arm_group_label>12-Hour Bed Rest</arm_group_label>
    <arm_group_label>24-Hour Bed Rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Received thrombectomy (may have also received intravenous tPA) for a diagnosis of
             acute ischemic stroke

          -  TICI 2b/2c/3 score following thromectomy

          -  Patient and/or Legally Authorized Representative provide consent

        Exclusion Criteria:

          -  TICI 0/1/2a score following thrombectomy

          -  Venous thromboembolism present at symptom onset

          -  Pneumonia present at symptom onset

          -  STEMI at symptom onset

          -  Positive troponins at symptom onset according to local values

          -  Bone fracture at symptom onset

          -  Intubation anticipated or occurred

          -  Symptomatic intracranial hemorrhage (defined as increase in NIHSS by 4 points or more
             accompanied by PH2 hemorrhage on imaging) at the time of screening.

          -  Pre-screening systolic blood pressure &lt; 110 mmHg

          -  Resting pulse oximetry &lt; 92% (with or without supplemental oxygen)

          -  Neurological worsening (defined as NIHSS increase of 4 points compared to initial
             score) prior to screening.

          -  Baseline modified Rankin Scale score &gt; 2

          -  Known Pregnancy

          -  Patient not anticipated to survive 3 months

          -  Patient not anticipated to follow-up at 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Silver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMass Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian Silver, MD</last_name>
    <phone>508-334-2527</phone>
    <email>brian.silver@umassmemorial.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meaghan Demers-Peel, BS</last_name>
    <phone>774-455-6568</phone>
    <email>meaghan.demers-peel@umassmed.edu</email>
  </overall_contact_backup>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Worcester</investigator_affiliation>
    <investigator_full_name>Brian Silver</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Mobilization</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Cerebrovascular Disorders</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

